| Autor: |
Kumada, Takashi, Arai, Yasuaki, Itoh, Kazuki, Takayasu, Yukio, Nakamura, Kenji, Ariyoshi, Yutaka, Tajima, Kazuo |
| Předmět: |
|
| Zdroj: |
Oncology; 1999, Vol. 57 Issue 3, p216-223, 8p |
| Abstrakt: |
This multicenter phase II study evaluated the efficacy of the FEM regimen (5-fluorouracil 333 mg/m[sup 2] each week, epirubicin 30 mg/m[sup 2] once every 4 weeks and mitomycin-C 2.7 mg/m[sup 2] once every 2 weeks) administered by hepatic artery infusion (HAI) for unresectable hepatic metastases of gastric cancer. The response rates were 55.6% (complete response: 3, partial response: 32, no change: 21, progressive disease: 7/63) and the mean 50% survival was 10.5 months. Most responders died due to the progression of extrahepatic lesions. HAI of the FEM regimen induced a high response rate in patients with hepatic metastases of gastric cancer, and the prognosis-determining factor was the existence of extrahepatic lesions in many patients. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
